[Impella 5.5®：左心室辅助系统领域的最新创新]。

IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS

Giornale italiano di cardiologia Pub Date : 2025-06-01 DOI:10.1714/4501.45019

Gianpiero Buttiglione, Alessandra Francica, Marina Comisso, Marco Russo, Grazia Santoro, Vittoria Lodo, Matteo Matteucci, Michele Di Mauro, Francesco Pollari, Francesco Onorati, Fabio Barili, Alessandro Parolari, Michele Pilato

{"title":"[Impella 5.5®：左心室辅助系统领域的最新创新]。","authors":"Gianpiero Buttiglione, Alessandra Francica, Marina Comisso, Marco Russo, Grazia Santoro, Vittoria Lodo, Matteo Matteucci, Michele Di Mauro, Francesco Pollari, Francesco Onorati, Fabio Barili, Alessandro Parolari, Michele Pilato","doi":"10.1714/4501.45019","DOIUrl":null,"url":null,"abstract":"The Impella 5.5® (Abiomed Inc., Danvers, MA, USA) is a temporary mechanical circulatory support device utilized for the management of cardiogenic shock. In this review, we outline the device's key features, paying particular attention to its indications and contraindications, the surgical technique for implantation, and potential complications. Additionally, we emphasize the potential benefits of using the Impella as a bridge to left ventricular assistance device implantation, a safe strategy to mitigate the risk of right heart failure.","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"26 6","pages":"389-394"},"PeriodicalIF":0.7000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Impella 5.5®: the latest innovation in the field of left ventricular assist systems].\",\"authors\":\"Gianpiero Buttiglione, Alessandra Francica, Marina Comisso, Marco Russo, Grazia Santoro, Vittoria Lodo, Matteo Matteucci, Michele Di Mauro, Francesco Pollari, Francesco Onorati, Fabio Barili, Alessandro Parolari, Michele Pilato\",\"doi\":\"10.1714/4501.45019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The Impella 5.5® (Abiomed Inc., Danvers, MA, USA) is a temporary mechanical circulatory support device utilized for the management of cardiogenic shock. In this review, we outline the device's key features, paying particular attention to its indications and contraindications, the surgical technique for implantation, and potential complications. Additionally, we emphasize the potential benefits of using the Impella as a bridge to left ventricular assistance device implantation, a safe strategy to mitigate the risk of right heart failure.\",\"PeriodicalId\":12510,\"journal\":{\"name\":\"Giornale italiano di cardiologia\",\"volume\":\"26 6\",\"pages\":\"389-394\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Giornale italiano di cardiologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1714/4501.45019\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Giornale italiano di cardiologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1714/4501.45019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

摘要

Impella 5.5®（Abiomed Inc., Danvers， MA， USA）是一种用于心源性休克管理的临时机械循环支持装置。在这篇综述中，我们概述了该装置的主要特点，特别注意其适应症和禁忌症，植入手术技术和潜在的并发症。此外，我们强调使用Impella作为左心室辅助装置植入的桥梁的潜在益处，这是一种降低右心衰竭风险的安全策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

[Impella 5.5®: the latest innovation in the field of left ventricular assist systems].

The Impella 5.5® (Abiomed Inc., Danvers, MA, USA) is a temporary mechanical circulatory support device utilized for the management of cardiogenic shock. In this review, we outline the device's key features, paying particular attention to its indications and contraindications, the surgical technique for implantation, and potential complications. Additionally, we emphasize the potential benefits of using the Impella as a bridge to left ventricular assistance device implantation, a safe strategy to mitigate the risk of right heart failure.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Giornale italiano di cardiologia CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

1.10

自引率

0.00%

发文量